Key points are not available for this paper at this time.
Patients receiving prehospital PRBC+plasma had the greatest mortality benefit. Crystalloid only had the worst survival. Patients with hemorrhagic shock should receive prehospital blood products when available, preferably PRBC+plasma. Prehospital whole blood may be ideal in this population.
Guyette et al. (Tue,) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: